PTPRC and neoplasm: Our findings revealed that MH treatment not only increased the infiltration of intratumoral T cells but also enhanced their cytotoxic potential, as shown by the elevated levels of IFN-γ and granzyme-B in purified CD45+ immune cells from tumor tissue.